Providing statistical and data management support for cancer immunotherapy research
Core B: Biostatistics and Informatics
This study is all about helping researchers improve cancer immunotherapy trials by providing support with data collection and analysis, so they can better understand how treatments work and ensure they meet important standards for patient care.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Roswell Park Cancer Institute Corp NIH-funded |
| Lab location | 1 site (Buffalo, United States) |
| Project ID | NIH-10916169 on NIH RePORTER |
What this research studies
This research focuses on offering essential biostatistical and informatics support to enhance the quality and validity of cancer immunotherapy studies. The Biostatistics and Informatics Core will assist researchers in designing clinical trials, ensuring proper data collection, and interpreting results accurately. By applying innovative statistical methods, the core aims to improve the execution of multiple clinical trials targeting the chemokine system in tumors. This collaborative effort will help researchers meet regulatory standards and enhance the overall quality of their findings.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are individuals diagnosed with cancer who may be involved in clinical trials targeting immunotherapy.
Not a fit: Patients with non-cancerous conditions or those not eligible for clinical trials may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer immunotherapy treatments by ensuring high-quality data and robust statistical analyses.
How similar studies have performed: Previous research has demonstrated success in utilizing biostatistical and informatics support to enhance clinical trial outcomes, making this approach well-established.
Where this research is happening
Buffalo, United States
- Roswell Park Cancer Institute Corp — Buffalo, United States (Active)
Researchers
- Principal investigator: Yu, Han — Roswell Park Cancer Institute Corp
- Study coordinator: Yu, Han
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.